Axovant Sciences Ltd

0.00 (0.0%)

Axovant Sciences Financial Summary

The current 0JRU market cap is 0. The company's latest EPS is -0.975 and P/E is N/A.

Year End 31 March 20182019202020212022
Total Revenue 00000
Operating Income -213.32M-127.02M-69.17M-42.2M-71.56M
Net Income -221.57M-129.07M-72.63M-32.43M-71.89M
Year End 31 March 20182019202020212022
Total Assets 160.79M122.71M93.68M135.15M75.08M
Total Liabilities 89.5M66.49M32.12M11.78M14.73M
Total Equity 71.29M56.21M61.56M123.37M60.35M
Year End 31 March 20182019202020212022
Operating -190.35M-134.21M-67.47M-46.59M-60.35M
Investing -4.28M-202k-255k12.39M3.65M
Financing 136.4M87.07M41.48M73.62M1.44M
Market Cap 0
Price to Earnings Ratio N/A
Price to Sales Ratio
Price to Cash Ratio
Price to Book Ratio
Dividend Yield -

Share Statistics

Shares Outstanding 73.74M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) (%)

Company Info

Company Name Axovant Sciences Ltd
Address suite 1
london 10036
Website https://
Industry pharmaceutical preparations (2834)
Your Recent History
Axovant Sc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230607 09:17:49